top of page

Sigma-1 Receptor Agonists as Potential Treatment Options for Autism Spectrum Disorders

  • Writer: ANAVEX® Life Sciences Corp.
    ANAVEX® Life Sciences Corp.
  • Jun 11, 2016
  • 1 min read

Gordon Research Conference for Fragile X and Autism-Related Disorders, Mount Snow, VT

Patricia Cogram, Daniel Klamer, Nell Rebowe, Jeffrey Sprouse, Christopher U. Missling


 
 
bottom of page